Skip to content
10-Q

Quarterly Report

AEOLUS PHARMACEUTICALS, INC.

0001102624-15-000841

← back to feed
Filed
May 15, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · May 15, 2015 135.85M sh
Stockholders Equity Q2 2015 · Mar 31, 2015 $434K
Stockholders Equity Q2 2015 · Sep 30, 2014 $1.59M
Current Liabilities Q2 2015 · Mar 31, 2015 $1.81M
Current Liabilities Q2 2015 · Sep 30, 2014 $2M
Total Liabilities Q2 2015 · Mar 31, 2015 $1.81M
Total Liabilities Q2 2015 · Sep 30, 2014 $2M
Current Assets Q2 2015 · Mar 31, 2015 $2.22M
Current Assets Q2 2015 · Sep 30, 2014 $3.55M
Total Assets Q2 2015 · Mar 31, 2015 $2.25M
Total Assets Q2 2015 · Sep 30, 2014 $3.58M
Shares Diluted Q2 2015 · Sep 30, 2014 135.85K sh
Shares Diluted Q2 2015 · Mar 31, 2014 134.55K sh
Shares Diluted Q2 2015 · Sep 30, 2013 134.55K sh
Eps Diluted Q2 2015 · Sep 30, 2014 −$0.01
Eps Diluted Q2 2015 · Mar 31, 2014 −$0.01
Eps Diluted Q2 2015 · Sep 30, 2013 $0.00
Eps Basic Q2 2015 · Sep 30, 2014 −$0.01
Eps Basic Q2 2015 · Mar 31, 2014 −$0.01
Eps Basic Q2 2015 · Sep 30, 2013 $0.00
Sga Expense Q2 2015 · Sep 30, 2014 $604K
Sga Expense Q2 2015 · Mar 31, 2014 $1.48M
Sga Expense Q2 2015 · Sep 30, 2013 $702K
Rd Expense Q2 2015 · Sep 30, 2014 $1.3M
Rd Expense Q2 2015 · Mar 31, 2014 $1.88M
Rd Expense Q2 2015 · Sep 30, 2013 $1.17M
Net Income Q2 2015 · Sep 30, 2014 −$712K
Net Income Q2 2015 · Mar 31, 2014 −$1.13M
Net Income Q2 2015 · Sep 30, 2013 −$437K
Operating Income Q2 2015 · Sep 30, 2014 −$712K
Operating Income Q2 2015 · Mar 31, 2014 −$1.13M
Operating Income Q2 2015 · Sep 30, 2013 −$437K
Operating Cash Flow Q2 2015 · Mar 31, 2014 −$349K
Cash And Equivalents Q2 2015 · Mar 31, 2014 $520K
Cash And Equivalents Q2 2015 · Sep 30, 2013 $869K